LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) › Net IncomeLIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2006: -$562.1K2007: -$1.65M2008: -$1.27M2009: -$1.55M2010: -$880.2K2011: -$2.07M2012: -$3.58M2013: -$1.37M2014: -$2.77M2015: -$2.85M2016: -$2.13M2017: -$1.81M2018: -$2.13M2019: -$2.44M2020: -$3.26M2021: -$6.73M2022: -$6.31M2023: -$5.09M2024: -$3.59M2025: -$6.08M-$6.08M2006Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$6.08M-69.5%2024-$3.59M+29.5%2023-$5.09M+19.4%2022-$6.31M+6.2%2021-$6.73M-106.1%2020-$3.26M-33.8%2019-$2.44M-14.4%2018-$2.13M-18.0%2017-$1.81M+15.3%2016-$2.13M+25.2%2015-$2.85M-3.1%2014-$2.77M-101.2%2013-$1.37M+61.6%2012-$3.58M-73.1%2011-$2.07M-134.9%2010-$880.2K+43.3%2009-$1.55M-22.0%2008-$1.27M+22.9%2007-$1.65M-193.3%2006-$562.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share